Recent

% | $
Quotes you view appear here for quick access.

Amarin Corporation plc Message Board

you are viewing a single comment's thread.

view the rest of the posts
  • mtdsus mtdsus Sep 18, 2012 12:03 PM Flag

    AMRN at AMCP's Educational Conference Oct 3-5, 2012 (managed care)

    Could you provide more details about Attendees etc?
    Purpose of this conference
    Some example of other Products that used this platform for communication in the past?

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • Here's their listing of types of attendees:

      Managed Care Executives
      Pharmacy Directors
      Medical Directors
      Academia
      Professional Relations
      Outcomes Research Professionals
      Medical Affairs Pharmacist
      Clinical Coordinators
      Case Managers/RNs
      Residents and Fellows
      Student Pharmacists

      And here's an example from the schedule. AMRN will also participate in The Exchange (see above post):

      11:30 am - 12:00 pm Purdue Pharma L.P.
        Middle-of-the-Night Awakenings: Matching Insomnia Therapy to Patient Need
        Diagnosis and appropriate management of insomnia are important aspects of patient care. Attend the Purdue Pharma L.P. Product Theater “Middle-of-the-Night Awakenings: Matching Insomnia Therapy to Patient Need” to learn about a treatment option now available.
      Speaker: Russell Rosenberg, PhD
         
      11:30 am - 12:00 pm Forest Pharmaceuticals, Inc.
        This program will evaluate the impact of COPD, review the 2011 GOLD guidelines, discuss goals for improving lung function and present a treatment option for the management of COPD.
      Speaker: Shari Fine, DO
         
      12:15 pm - 12:45 pm VIVUS, Inc.
        A New Once-Daily Treatment for Obesity
        This program will evaluate the impact of obesity on related risk factors and discuss the clinical guidelines and evolving treatment landscape in obesity.
      Speaker: Barbara Troupin, MD, MBA
         
      12:15 pm - 12:45 pm AMARIN
        Vascepa™: A new therapy for the treatment of severe hypertriglyceridemia
         
      Friday, October 5th

       
         
      8:30 am - 9:00 am Pfizer Inc
        Neuropathic Pain Associated with Spinal Cord Injury
        This 30-minute presentation will focus on characterization of neuropathic pain associated with spinal cord injury and its personal and societal burden. Dr. Liss will present clinical trial data and important managed care perspectives. This presentation will include a question-and answer session.
      Speaker:
      Jonathan L. Liss, MD
      Medical Director
      Muscogee Manor & Rehabilitation Center
      Columbus, GA

      Sentiment: Strong Buy

    • Eric Boothe Manager, Managed Care, Amarin & Joseph Gilhooly, Director, Managed Care, Amarin are on the Attendee List. Amarin at Table 9 and Virtual Hall. See other posts for other events. Gilead and Merck are the Silver Sponsors, Lilly and Pfizer are the Bronze Sponsors.

      Sentiment: Strong Buy

 
AMRN
3.08+0.01(+0.33%)Aug 26 4:00 PMEDT